| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Feb 27, 2017 | EXAS Exact Sciences Corp | Arora Maneesh | COO | Sell | 11,114 | $21.50 | $238,968.30 | -1.0% | |
| Feb 24, 2017 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 3,600 | $8.45 | $30,436.00 | - | |
| Feb 24, 2017 | DHR Danaher Corp /de/ | Lutz Robert S | Svp-chief Accounting Officer | Sell | 37,870 | $85.60 | $3,241,596.26 | -59.1% | |
| Feb 23, 2017 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 1,800 | $8.39 | $15,101.50 | - | |
| Feb 23, 2017 | MYGN Myriad Genetics Inc | Henderson John T65 | Director | Buy | 6,000 | $18.66 | $111,930.20 | +5.1% | |
| Feb 22, 2017 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 8,658 | $87.85 | $760,562.36 | - | |
| Feb 22, 2017 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 9,717 | $87.64 | $851,591.84 | -0.1% | |
| Feb 22, 2017 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 1,800 | $8.54 | $15,371.00 | - | |
| Feb 22, 2017 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 3,404 | $88.22 | $300,300.28 | - | |
| Feb 21, 2017 | RVTY Revvity, Inc. | Michas Alexis P68 | Director | Sell | 8,308 | $55.60 | $461,924.80 | -13.5% | |
| Feb 21, 2017 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 3,600 | $8.80 | $31,680.00 | - | |
| Feb 17, 2017 | AWHL Aspira Women's Health Inc. | Feinberg Larry N | 10% Owner, * See Remarks | Buy | 617,731 | $1.40 | $864,823.40 | +6.7% | |
| Feb 17, 2017 | MTD Mettler Toledo International Inc/ | Spoerry Robert F70 | Director | Sell | 3,000 | $470.00 | $1,410,000.00 | -34.9% | |
| Feb 17, 2017 | WAT Waters Corp /de/ | Khanna Rohit | SVP, Applied Technology | Sell | 1,078 | $153.50 | $165,473.00 | -20.9% | |
| Feb 17, 2017 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 1,800 | $8.80 | $15,836.00 | - | |
| Feb 16, 2017 | MTD Mettler Toledo International Inc/ | Filliol Oliver A71 | President And CEO | Sell | 15,000 | $464.30 | $6,964,562.28 | -14.7% | |
| Feb 16, 2017 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 1,800 | $8.65 | $15,570.00 | - | |
| Feb 16, 2017 | A Agilent Technologies, Inc. | Kaltenbach Patrick | Sr Vice President | Sell | 3,771 | $51.68 | $194,885.28 | -8.6% | |
| Feb 15, 2017 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 1,800 | $8.46 | $15,228.00 | - | |
| Feb 15, 2017 | A Agilent Technologies, Inc. | Hirsch Didier | Sr. VP And CFO | Sell | 22,258 | $51.50 | $1,146,287.00 | -11.7% | |
| Feb 15, 2017 | DHR Danaher Corp /de/ | Lohr Walter G51 | Director | Sell | 10,578 | $84.32 | $891,936.96 | -56.2% | |
| Feb 15, 2017 | DHR Danaher Corp /de/ | Schwieters John T | Director | Sell | 10,578 | $84.29 | $891,619.62 | -28.0% | |
| Feb 15, 2017 | RVTY Revvity, Inc. | Singh Prahlad R.53 | Please See Remarks | Sell | 9,576 | $55.00 | $526,680.00 | -22.7% | |
| Feb 14, 2017 | CRL Charles River Laboratories International, Inc. | Milne George M Jr59 | Director | Sell | 10,710 | $86.52 | $926,629.20 | -27.3% | |
| Feb 14, 2017 | DHR Danaher Corp /de/ | Ehrlich Donald J | Director | Sell | 10,578 | $83.98 | $888,340.44 | -11.1% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.